
Kansai Nerolac (KANSAINER) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
21.6B
Gross Profit
7.8B
36.08%
Operating Income
2.5B
11.57%
Net Income
2.2B
9.97%
EPS (Diluted)
₹2.73
Balance Sheet Metrics
Total Assets
82.2B
Total Liabilities
18.1B
Shareholders Equity
64.0B
Debt to Equity
0.28
Cash Flow Metrics
Revenue & Profitability Trend
Kansai Nerolac Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 77.9B | 77.7B | 75.1B | 62.8B | 50.4B |
Cost of Goods Sold | 51.1B | 50.8B | 53.0B | 44.6B | 31.7B |
Gross Profit | 26.8B | 26.9B | 22.1B | 18.3B | 18.7B |
Gross Margin % | 34.4% | 34.6% | 29.4% | 29.1% | 37.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 8.1B | 8.2B | 6.8B | 6.0B | 4.7B |
Other Operating Expenses | 4.4B | 4.1B | 3.5B | 2.9B | 2.5B |
Total Operating Expenses | 12.5B | 12.2B | 10.3B | 8.9B | 7.2B |
Operating Income | 7.4B | 8.4B | 6.4B | 4.8B | 7.0B |
Operating Margin % | 9.5% | 10.8% | 8.5% | 7.6% | 13.8% |
Non-Operating Items | |||||
Interest Income | 93.8M | 44.5M | 28.4M | 25.9M | 62.0M |
Interest Expense | 312.5M | 292.1M | 290.0M | 277.9M | 236.1M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 14.8B | 15.6B | 6.3B | 4.8B | 7.1B |
Income Tax | 3.7B | 3.9B | 1.7B | 1.3B | 1.9B |
Effective Tax Rate % | 24.9% | 24.7% | 26.2% | 28.0% | 26.2% |
Net Income | 11.1B | 11.8B | 4.7B | 3.4B | 5.3B |
Net Margin % | 14.2% | 15.1% | 6.2% | 5.5% | 10.4% |
Key Metrics | |||||
EBITDA | 9.3B | 10.5B | 8.2B | 6.6B | 8.8B |
EPS (Basic) | ₹14.14 | ₹14.66 | ₹5.86 | ₹4.44 | ₹6.55 |
EPS (Diluted) | ₹14.12 | ₹14.65 | ₹5.86 | ₹4.44 | ₹6.55 |
Basic Shares Outstanding | 808435265 | 808379580 | 808379580 | 808379580 | 808379580 |
Diluted Shares Outstanding | 808435265 | 808379580 | 808379580 | 808379580 | 808379580 |
Income Statement Trend
Kansai Nerolac Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 940.0M | 1.7B | 1.0B | 770.4M | 1.0B |
Short-term Investments | 20.4B | 14.1B | 5.2B | 2.4B | 6.9B |
Accounts Receivable | 13.6B | 13.3B | 12.4B | 10.9B | 9.6B |
Inventory | 16.7B | 16.9B | 17.3B | 16.3B | 12.0B |
Other Current Assets | 1.7B | -500.0K | -500.0K | 1.7B | 1.7B |
Total Current Assets | 53.5B | 47.5B | 38.0B | 32.3B | 31.8B |
Non-Current Assets | |||||
Property, Plant & Equipment | 837.1M | 815.6M | 809.4M | 801.6M | 792.2M |
Goodwill | 204.1M | 562.8M | 569.7M | 663.8M | 795.8M |
Intangible Assets | 154.7M | 167.2M | 174.1M | 268.2M | 400.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 949.7M | 1.1B | 883.1M | 876.4M | 901.9M |
Total Non-Current Assets | 28.6B | 26.6B | 25.0B | 24.8B | 23.6B |
Total Assets | 82.2B | 74.1B | 63.1B | 57.1B | 55.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 11.0B | 11.0B | 10.2B | 9.8B | 9.1B |
Short-term Debt | 1.2B | 1.4B | 1.8B | 2.2B | 1.7B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 463.5M | 1.5B | 2.0B | 325.9M | 224.1M |
Total Current Liabilities | 14.5B | 15.2B | 15.1B | 13.3B | 12.4B |
Non-Current Liabilities | |||||
Long-term Debt | 1.8B | 1.4B | 1.0B | 1.0B | 943.1M |
Deferred Tax Liabilities | 1.6B | 1.3B | 1.1B | 1.1B | 1.1B |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 3.6B | 2.9B | 2.4B | 2.3B | 2.0B |
Total Liabilities | 18.1B | 18.1B | 17.5B | 15.6B | 14.4B |
Equity | |||||
Common Stock | 808.4M | 808.4M | 538.9M | 538.9M | 538.9M |
Retained Earnings | 58.4B | 50.1B | 39.7B | 35.8B | 35.0B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 64.0B | 56.0B | 45.6B | 41.5B | 40.9B |
Key Metrics | |||||
Total Debt | 3.0B | 2.8B | 2.9B | 3.2B | 2.7B |
Working Capital | 39.0B | 32.3B | 23.0B | 19.0B | 19.4B |
Balance Sheet Composition
Kansai Nerolac Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 14.8B | 15.6B | 6.3B | 4.8B | 7.1B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | -15.3M | 121.5M | 37.5M | 7.3M | - |
Working Capital Changes | -795.1M | -93.8M | -3.0B | -5.4B | -4.0B |
Operating Cash Flow | 14.2B | 15.9B | 3.7B | -344.7M | 3.3B |
Investing Activities | |||||
Capital Expenditures | -3.3B | -2.4B | -1.2B | -2.2B | -1.0B |
Acquisitions | - | - | - | - | 0 |
Investment Purchases | -55.3B | -52.2B | -27.8B | -30.2B | -32.9B |
Investment Sales | 49.6B | 44.0B | 25.1B | 34.9B | 29.3B |
Investing Cash Flow | -10.0B | -7.0B | -3.9B | 2.5B | -4.6B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -3.0B | -1.5B | -551.8M | -2.8B | -2.4B |
Debt Issuance | 150.0M | 150.0M | 0 | - | 0 |
Debt Repayment | 0 | -575.0M | -218.4M | -500.0K | -49.6M |
Financing Cash Flow | -3.0B | -2.4B | -926.1M | -2.6B | -2.3B |
Free Cash Flow | 3.5B | 6.7B | 2.9B | -1.9B | 5.4B |
Net Change in Cash | 1.2B | 6.4B | -1.2B | -446.5M | -3.6B |
Cash Flow Trend
Kansai Nerolac Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.61
Forward P/E
24.11
Price to Book
2.93
Price to Sales
2.39
PEG Ratio
-4.68
Profitability Ratios
Profit Margin
14.43%
Operating Margin
11.57%
Return on Equity
17.85%
Return on Assets
13.91%
Financial Health
Current Ratio
3.69
Debt to Equity
4.63
Beta
0.02
Per Share Data
EPS (TTM)
₹14.00
Book Value per Share
₹79.45
Revenue per Share
₹97.06
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
kansainer | 188.0B | 16.61 | 2.93 | 17.85% | 14.43% | 4.63 |
Asian Paints | 2.4T | 65.80 | 12.24 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.77 | 16.03 | 20.85% | 16.16% | 4.56 |
Atul | 195.2B | 39.07 | 3.49 | 8.55% | 8.71% | 3.56 |
BASF India | 199.1B | 50.25 | 5.48 | 13.18% | 2.61% | 5.23 |
Vinati Organics | 177.1B | 42.37 | 6.15 | 15.42% | 18.03% | 2.24 |
Financial data is updated regularly. All figures are in the company's reporting currency.